U.S. Energy Boom Ke...
Health Care: Drugs
Tekmira Pharmaceuticals Corporation (TKMR: NASDAQ)
$4.71 -0.04 | -0.80%
05/24/13 - 03:59 PM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with TKMR
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
Latest TKMR Headlines from TheStreet
- Tekmira's Collaborators At The National Cancer Institute Present Preclinical Data At The Annual Meeting Of The American Association For Cancer Research (AACR) 04.10.13 | 08:04 am
- Tekmira Presents Data From Its TKM-PLK1 Phase I Clinical Trial At American Association For Cancer Research (AACR) Meeting 04.09.13 | 03:04 pm
- Tekmira Provides Corporate Update And Announces Year-End Audited 2012 Results 03.27.13 | 04:03 pm
- 5 Stocks Under $10 Triggering Breakouts 03.21.13 | 01:03 pm
- Tekmira Conference Call And Webcast Advisory: Corporate Update And Year-End 2012 Financial Results 03.20.13 | 04:03 pm
- Tekmira Outlines Key 2013 Product Development And Corporate Milestones 02.12.13 | 08:02 am
- Tekmira To Webcast Presentation At 15th Annual BIO CEO & Investor Conference 02.06.13 | 08:02 am
- Tekmira To Present TKM-PLK1 Phase 1 Clinical Trial Results At AACR 02.04.13 | 08:02 am
- Tekmira's LNP Technology Highlighted In Peer-Reviewed Publication, Cancer Discovery 01.31.13 | 04:01 pm
- 3 Pharma Stocks Leaping on Unusual Volume 01.10.13 | 02:01 pm
Press Releases for TKMR
Partner Headlines for TKMR
- Tekmira Says Expects to Receive Notice by Sept 30 on DoD's Decision Related to Order on TKM-EBOLA Program - Benzinga 08.31.12 | 04:08 pm
- What Alnylam Doesn't Want You To Know - Seeking Alpha 03.16.12 | 09:03 am
- Tekmira: RNAi Company With Long Term Potential, Short Term Catalysts - Seeking Alpha 03.07.12 | 08:03 am
- Tekmira Provides Periodic Update to Litigation; Alnylam Pharma Files Suit Against Tekmira - Benzinga 01.17.12 | 04:01 pm
- Tekmira Granted an Injunction Against Certain Individuals From AlCana Technologies by the Supreme Court of British Columbia - Benzinga 01.10.12 | 04:01 pm
- Morning Market Losers - Benzinga 12.19.11 | 09:12 am
- Tekmira and Collaborators Present Data at the AACRMeeting on Tekmira's Lead Oncology Product, TKM-PLK1, and an Oncology Product Candidate Targeting Kinase WEE1 - Benzinga 04.04.11 | 04:04 pm
- Tekmira Sues Alnylam Pharmaceuticals for Repeated Misuse of Trade Secrets and Confidential Information - Benzinga 03.16.11 | 04:03 pm
